Form 4: Alzamend Neuro Insider Receives Stock Grant
Insider Transaction (Form 4)
Hyperscale Data, Inc. reported changes in beneficial ownership of Alzamend Neuro, Inc. common stock on July 31, 2026.
Summary
- Grant/award: acquired 7,500 Series D Convertible Preferred Stock at $1,000.00 ($7,500,000) on July 31, 2026; holds 7,500 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Hyperscale Data, Inc. — Director, Other (Director by deputization)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Grant/award | Series D Convertible Preferred Stock | 7,500 | $1.0K | $7.5M | 7,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Grant/award (7,500 shares) |
Keywords
insider transaction, Form 4, ALZN, Alzamend Neuro, Inc., neutral, Hyperscale Data, Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.